Registry that tracks immune-related inflammatory disease
Part of Bones, joints & muscles, Brain & nervous system, Digestive system, Immune system & allergy, Skin clinical trials.
This study is a registry that collects information about people diagnosed with immune-related inflammatory diseases (IMID) and how they are treated. It may help doctors better understand these conditions and improve monitoring over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of an immune-related inflammatory disease (IMID)
- You can be any age, including children and teens
- You must be using approved treatments for your condition and/or receiving light therapy (phototherapy)
- You must agree to sign the informed consent form
- If you do not have an IMID diagnosis, you cannot join
- If you cannot or will not sign informed consent, you cannot join
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry study tracks people with immune-mediated inflammatory diseases (like rheumatoid arthritis or lupus) to better understand their risk of heart disease. It aims to improve prevention and care by collecting health information over time.
This is a registry study that collects health information from people with multiple sclerosis and related conditions. By joining, you help researchers better understand these diseases and improve future treatments.
This study is a registry that collects information from people diagnosed with certain neuroinflammation conditions. It may help doctors learn how these diseases behave over time and support future research.
This is a study that follows people with an immune-related illness at Lille University Hospital to better understand their care needs over time. By collecting information regularly, the study may help improve how future patients are monitored and treated.
This is a long-term study that evaluates and follows patients with inflammatory conditions related to infections or immune system problems. Researchers at the National Institutes of Health want to understand these conditions better and may ask you to participate in related studies.
This study is creating a group of patients with idiopathic inflammatory myositis (a condition where your immune system attacks your muscles) to better understand the disease and improve care. It's open to adults ages 18 to 75 who have been diagnosed using specific medical guidelines.
Hear when a new ImmuNe-Mediated Inflammatory Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.